“…T9300A, Takara Bio Inc., Shiga, Japan). Immunoblotting was performed as described by Kamimura et al (2020). The primary antibody reactions were performed using the following antibodies appropriately diluted to each target protein: anti-cleaved poly(ADP-ribose) polymerase (PARP; 1:1,000, #5625, Cell Signaling Technology, Inc., MA, USA), antidipeptidyl peptidase 4 (DPP4; 1:1,000, #67138, Cell Signaling Technology), anti-Krüppel-like factor 4 (KLF4; 1:500, #12173, Cell Signaling Technology), anti-villin (1:500, 66096-1-Ig, Proteintech Group, Inc., IL, USA), and anti-β-actin (1:10,000, 66009-1-Ig, Proteintech).…”